# BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment

> **NCT03361111** · — · COMPLETED · sponsor: **Medical University of Warsaw** · enrollment: 16 (actual)

## Conditions studied

- Severe Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03361111
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-04
- **Primary completion:** 2018-11-05
- **Final completion:** 2018-12-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03361111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03361111, "BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03361111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*